In 2006, Oregon successfully made pseudoephedrine, a key ingredient of meth, a prescription drug. Since then, Mother Jones' Jonah Engle reports, 24 states have tried to follow suit -- and 23 have failed. Engle attributes those failures to pharmaceutical companies' massive lobbying efforts.